Author response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease

Volume: 94, Issue: 20, Pages: 899 - 899
Published: May 19, 2020
Abstract
We appreciate the comments from Drs. Scherzer, Riise, and Locascio on our article1 on the effects of β2-adrenoceptor (β2AR) antagonists and agonists and risk of Parkinson disease (PD). Since the initial publication,2 this hypothesis has been scrutinized by multiple groups, yielding conflicting...
Paper Details
Title
Author response: Use of β2-adrenoreceptor agonist and antagonist drugs and risk of Parkinson disease
Published Date
May 19, 2020
Journal
Volume
94
Issue
20
Pages
899 - 899
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.